Experience of Applying TNF--inhibitors (Adalimumab and Etanercept) while Treating a Patient with Juvenile Arthritis and Eye Failure
The article presents a seven-year-long monitoring of a patient with juvenile arthritis and eye problems who is refractory to the standard basic immunosuppressive drugs therapy. High efficiency of both tumor necrosis factor (TNF) receptor blocker etanercept and recombinant antibody to TNF- adalimumab...
Saved in:
Main Author: | T. I. Korovkina (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α - ADALIMUMAB - IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013) -
EFFICACY OF USE OF TNF INHIBITOR ADALIMUMAB IN A FEMALE PATIENT WITH CHRONIC UVEITIS IN THE ONSET OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Pavkhun, et al.
Published: (2016) -
EXPERIENCE OF TREATMENT OF JUVENILE POLYARTHRITIS WITH EYES LESION WITH ADALIMUMAB
by: A.O. Lisitsin, et al.
Published: (2008) -
EXPERIENCE OF TREATMENT OF JUVENILE POLYARTHRITIS WITH EYES LESION WITH ADALIMUMAB
by: A.O. Lisitsin, et al.
Published: (2008) -
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
by: Anders Öman, et al.
Published: (2021)